529 related articles for article (PubMed ID: 15531479)
1. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
2. A-type lamin-linked lipodystrophies.
Vigouroux C; Capeau J
Novartis Found Symp; 2005; 264():166-77; discussion 177-82, 227-30. PubMed ID: 15773753
[TBL] [Abstract][Full Text] [Related]
3. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
4. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
[TBL] [Abstract][Full Text] [Related]
6. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.
Lüdtke A; Genschel J; Brabant G; Bauditz J; Taupitz M; Koch M; Wermke W; Worman HJ; Schmidt HH
Am J Gastroenterol; 2005 Oct; 100(10):2218-24. PubMed ID: 16181372
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
10. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
[TBL] [Abstract][Full Text] [Related]
11. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation.
Araújo-Vilar D; Loidi L; Domínguez F; Cabezas-Cerrato J
Horm Metab Res; 2003 Jan; 35(1):29-35. PubMed ID: 12669268
[TBL] [Abstract][Full Text] [Related]
13. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
14. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
15. Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations.
Carboni N; Mura M; Marrosu G; Cocco E; Marini S; Solla E; Mateddu A; Maioli MA; Piras R; Mallarini G; Mercuro G; Porcu M; Marrosu MG
Muscle Nerve; 2010 Apr; 41(4):458-63. PubMed ID: 19882644
[TBL] [Abstract][Full Text] [Related]
16. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance.
Boschmann M; Engeli S; Moro C; Luedtke A; Adams F; Gorzelniak K; Rahn G; Mähler A; Dobberstein K; Krüger A; Schmidt S; Spuler S; Luft FC; Smith SR; Schmidt HH; Jordan J
J Clin Endocrinol Metab; 2010 Apr; 95(4):1634-43. PubMed ID: 20130076
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy.
Hegele RA; Kraw ME; Ban MR; Miskie BA; Huff MW; Cao H
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):111-6. PubMed ID: 12524233
[TBL] [Abstract][Full Text] [Related]
18. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
19. Multisystem disorder and limb girdle muscular dystrophy caused by LMNA p.R28W mutation.
Türk M; Wehnert M; Schröder R; Chevessier F
Neuromuscul Disord; 2013 Jul; 23(7):587-90. PubMed ID: 23746545
[TBL] [Abstract][Full Text] [Related]
20. Limb-girdle muscular dystrophy with severe heart failure overlapping with lipodystrophy in a patient with LMNA mutation p.Ser334del.
Madej-Pilarczyk A; Niezgoda A; Janus M; Wojnicz R; Marchel M; Fidziańska A; Grajek S; Hausmanowa-Petrusewicz I
J Appl Genet; 2017 Feb; 58(1):87-91. PubMed ID: 27585670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
